About Us
The goal of BE COMPANY is to deliver service by enabling access to quality pharmaceuticals through establishing that generic drugs are therapeutically equivalent to innovator drugs in the manner of absorption and distribution in the body or how well the drug performs in the body. Phases I and II clinical trial studies will also be included in the scope of BE COMPANY to provide research and development (R&D) access to new drug molecules for different diseases such as cancer, cardiovascular, diabetes and pandemics. It will also improve the countries R&D especially for locally made herbal medicines, and for special populations such as pediatrics.
